Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-12-04
DOI
https://doi.org/10.3389/fphar.2025.1694311
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis

Huanmin Kang, Hanyue Xu, Xue Wu, Ming Zhang et al.
Frontiers in Pharmacology
Ocular Diseases and Behçet’s Syndrome
article

Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis

Huanmin Kang, Hanyue Xu, Xue Wu, Ming Zhang, Yufan Huang
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Natural Science Foundation of Sichuan Province
Openalex Percentile: Top 47%
Ocular Diseases and Behçet’s Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.